Literature DB >> 20467419

Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women.

Miriam A Bredella1, Martin Torriani, Reza Hosseini Ghomi, Bijoy J Thomas, Danielle J Brick, Anu V Gerweck, Clifford J Rosen, Anne Klibanski, Karen K Miller.   

Abstract

Recent studies have demonstrated an important physiologic link between bone and fat. Bone and fat cells arise from the same mesenchymal precursor cell within bone marrow, capable of differentiation into adipocytes or osteoblasts. Increased BMI appears to protect against osteoporosis. However, recent studies have suggested detrimental effects of visceral fat on bone health. Increased visceral fat may also be associated with decreased growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels which are important for maintenance of bone homeostasis. The purpose of our study was to assess the relationship between vertebral bone marrow fat and trabecular bone mineral density (BMD), abdominal fat depots, GH and IGF-1 in premenopausal women with obesity. We studied 47 premenopausal women of various BMI (range: 18-41 kg/m², mean 30 ± 7 kg/m²) who underwent vertebral bone marrow fat measurement with proton magnetic resonance spectroscopy (1H-MRS), body composition, and trabecular BMD measurement with computed tomography (CT), and GH and IGF-1 levels. Women with high visceral fat had higher bone marrow fat than women with low visceral fat. There was a positive correlation between bone marrow fat and visceral fat, independent of BMD. There was an inverse association between vertebral bone marrow fat and trabecular BMD. Vertebral bone marrow fat was also inversely associated with IGF-1, independent of visceral fat. Our study showed that vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 and BMD. This suggests that the detrimental effect of visceral fat on bone health may be mediated in part by IGF-1 as an important regulator of the fat and bone lineage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20467419      PMCID: PMC3593350          DOI: 10.1038/oby.2010.106

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  31 in total

1.  Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk.

Authors:  K K Miller; B M K Biller; J G Lipman; G Bradwin; N Rifai; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2004-11-30       Impact factor: 5.958

2.  MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women.

Authors:  W Shen; J Chen; M Punyanitya; S Shapses; S Heshka; S B Heymsfield
Journal:  Osteoporos Int       Date:  2006-12-01       Impact factor: 4.507

Review 3.  Bone remodeling, energy metabolism, and the molecular clock.

Authors:  Clifford J Rosen
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

4.  Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways.

Authors:  Elena J Moerman; Kui Teng; David A Lipschitz; Beata Lecka-Czernik
Journal:  Aging Cell       Date:  2004-12       Impact factor: 9.304

5.  Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study.

Authors:  D von Muhlen; S Safii; S K Jassal; J Svartberg; E Barrett-Connor
Journal:  Osteoporos Int       Date:  2007-05-11       Impact factor: 4.507

6.  The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men.

Authors:  Hideo Makimura; Takara Stanley; David Mun; Sung Min You; Steven Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2008-09-02       Impact factor: 5.958

7.  Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women.

Authors:  Cuilin Zhang; Kathryn M Rexrode; Rob M van Dam; Tricia Y Li; Frank B Hu
Journal:  Circulation       Date:  2008-03-24       Impact factor: 29.690

Review 8.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

9.  Increased bone marrow fat in anorexia nervosa.

Authors:  Miriam A Bredella; Pouneh K Fazeli; Karen K Miller; Madhusmita Misra; Martin Torriani; Bijoy J Thomas; Reza Hosseini Ghomi; Clifford J Rosen; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958

Review 10.  Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts.

Authors:  Ichiro Takada; Miyuki Suzawa; Kunihiro Matsumoto; Shigeaki Kato
Journal:  Ann N Y Acad Sci       Date:  2007-07-26       Impact factor: 5.691

View more
  140 in total

1.  Increased marrow adiposity in premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; David W Dempster; Emily M Stein; Thomas L Nickolas; Hua Zhou; Donald J McMahon; Ralph Müller; Thomas Kohler; Alexander Zwahlen; Joan M Lappe; Polly Young; Robert R Recker; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2012-06-14       Impact factor: 5.958

2.  Perspective: the bone-fat connection.

Authors:  Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2010-08       Impact factor: 2.199

Review 3.  Body composition and skeletal health: too heavy? Too thin?

Authors:  Alexander Faje; Anne Klibanski
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

Review 4.  Obesity-driven disruption of haematopoiesis and the bone marrow niche.

Authors:  Benjamin J Adler; Kenneth Kaushansky; Clinton T Rubin
Journal:  Nat Rev Endocrinol       Date:  2014-10-14       Impact factor: 43.330

Review 5.  Mechanisms of marrow adiposity and its implications for skeletal health.

Authors:  Annegreet G Veldhuis-Vlug; Clifford J Rosen
Journal:  Metabolism       Date:  2016-11-27       Impact factor: 8.694

6.  Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.

Authors:  Miriam A Bredella; Eleanor Lin; Danielle J Brick; Anu V Gerweck; Lindsey M Harrington; Martin Torriani; Bijoy J Thomas; David A Schoenfeld; Anne Breggia; Clifford J Rosen; Linda C Hemphill; Zida Wu; Nader Rifai; Andrea L Utz; Karen K Miller
Journal:  Eur J Endocrinol       Date:  2012-01-24       Impact factor: 6.664

7.  Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: the CARDIA study.

Authors:  Wei Shen; Rebecca Scherzer; Madeleine Gantz; Jun Chen; Mark Punyanitya; Cora E Lewis; Carl Grunfeld
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

8.  Reliable quantification of marrow fat content and unsaturation level using in vivo MR spectroscopy.

Authors:  Kaipin Xu; Sigurdur Sigurdsson; Vilmundur Gudnason; Trisha Hue; Ann Schwartz; Xiaojuan Li
Journal:  Magn Reson Med       Date:  2017-07-16       Impact factor: 4.668

Review 9.  Clinical implications of bone marrow adiposity.

Authors:  A G Veldhuis-Vlug; C J Rosen
Journal:  J Intern Med       Date:  2018-01-15       Impact factor: 8.989

10.  Water-fat MRI for assessing changes in bone marrow composition due to radiation and chemotherapy in gynecologic cancer patients.

Authors:  Patrick J Bolan; Luke Arentsen; Thanasak Sueblinvong; Yan Zhang; Steen Moeller; Jori S Carter; Levi S Downs; Rahel Ghebre; Douglas Yee; Jerry Froelich; Susanta Hui
Journal:  J Magn Reson Imaging       Date:  2013-02-28       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.